Interview with GENIXUS co-founders Kendall Foster & Seth Coombs

Hospitals are chaotic, and hospital pharmacy is a big part of that. From product shortages to high labor costs to confusion between lookalike products –all under the crush of life and death situations, there’s a lot to worry about.

But where others saw only headaches, GENIXUS co-founders Kendall Foster and Seth Coombs saw opportunity. They’ve combined their expertise and mobilized investors and partners to develop a platform to reinvent how critical care medicines are manufactured and delivered. 

Their first product —ready to administer Propofol— is already on the market and there’s a rich pipeline in development.

Health Business Group is a boutique healthcare consulting firm that develops growth strategies for companies like GENIXUS. Contact us to learn more.

Previous
Previous

Interview with Azra AI CEO Chris Cashwell

Next
Next

AI and computer vision in healthcare. Interview with Encord CEO Eric Landau